CDKN2A and neoplasm: Furthermore, a proteomic study aiming at characterizing new partners of the von Hippel Lindau (VHL) tumor suppressor, an essential component of the ubiquitin E3-ligase complex that mediates proteasomal-mediated degradation of HIFs, identified ARF as a partner of the long isoform of VHL.